At a glance
- Originator Institute of Microbial Chemistry
- Class Antibacterials; Glyoxylates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Gram-positive infections
Most Recent Events
- 26 Jul 2001 Launched for Gram-positive infections in Japan (Unknown route)
- 17 Jun 1998 Preclinical development for Gram-positive infections in Japan (Unknown route)